RBOT — Vicarious Surgical Share Price
0.000.00%
Last trade - 00:00- $49.06m
- -$0.04m
- 18
- 30
- 45
- 21
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.05 | ||
| Price to Tang. Book | 1.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -110.83% | ||
| Return on Equity | -87.4% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vicarious Surgical Inc. is a robotics company, developing technology to improve surgical procedures. The Company is combining advanced miniaturized robotics, computer science, sensing and three-dimensional (3D) visualization to build a single-port surgical robot, called the Vicarious Surgical System, that helps surgeons to perform minimally invasive surgery. The Vicarious Surgical System is capable of incision sizes of approximately 1.8 centimeters. The Vicarious Surgical System consists of a camera and instrument arms, surgeon console and patient cart. The Vicarious Surgical System has a high-performance stereoscopic camera that, when combined with robotic motion, provides full 360-degree viewing capability and is being developed to continuously map the depth of the abdominal cavity. The Vicarious Surgical System surgeon console is designed to provide all the systems necessary for the surgeon in visualizing the surgical field and controlling all the motions of the robot.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- September 16th, 2021
- Public Since
- September 4th, 2020
- No. of Shareholders
- 28
- No. of Employees
- 123
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New York Stock Exchange
- Shares in Issue
- 5,932,165
- Address
- 78 Fourth Avenue, WALTHAM, 02451
- Web
- https://www.vicarioussurgical.com/
- Phone
- +1 6178681700
- Auditors
- Deloitte & Touche LLP
Upcoming Events for RBOT
Q1 2025 Vicarious Surgical Inc Earnings Call
Vicarious Surgical Inc Annual Shareholders Meeting
Vicarious Surgical Inc Annual Shareholders Meeting
Q2 2025 Vicarious Surgical Inc Earnings Release
Similar to RBOT
Abbott Laboratories
New York Stock Exchange
Agilent Technologies
New York Stock Exchange
Alcon AG
New York Stock Exchange
Artivion
New York Stock Exchange
Avanos Medical
New York Stock Exchange
FAQ
What is the Vicarious Surgical share price?
As of Today at 23:59 UTC, shares in Vicarious Surgical are trading at $8.27. This share price information is delayed by 15 minutes.
How has the Vicarious Surgical share price performed this year?
Shares in Vicarious Surgical last closed at $8.27 and the price had moved by -8.54% over the past 365 days. In terms of relative price strength the Vicarious Surgical share price has underperformed the S&P500 Index by -17.53% over the past year.
What are the analyst and broker recommendations for Vicarious Surgical?
The overall consensus recommendation for Vicarious Surgical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Vicarious Surgical dividend yield?
Vicarious Surgical does not currently pay a dividend.
Does Vicarious Surgical pay a dividend?
Vicarious Surgical does not currently pay a dividend.
When does Vicarious Surgical next pay dividends?
Vicarious Surgical does not currently pay a dividend.
How do I buy Vicarious Surgical shares?
To buy shares in Vicarious Surgical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vicarious Surgical?
As of the previous close price of $8.27, shares in Vicarious Surgical had a market capitalisation of $49.06m.
Where are Vicarious Surgical shares listed?
Here are the trading details for Vicarious Surgical:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: RBOT
What kind of share is Vicarious Surgical?
Based on an overall assessment of its quality, value and momentum Vicarious Surgical is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vicarious Surgical share price forecast for 2025?
The analyst consensus target price for shares in Vicarious Surgical is $10.75. That is 29.99% above the last closing price of $8.27.
Analysts covering Vicarious Surgical currently have a consensus Earnings Per Share (EPS) forecast of -$8.71 for the next financial year.
Find out moreWhat is the trend in the Vicarious Surgical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vicarious Surgical. Over the past six months, its share price has outperformed the S&P500 Index by +2.82%.
As of the last closing price of $8.27, shares in Vicarious Surgical were trading -10.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vicarious Surgical PE Ratio?
The Vicarious Surgical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $8.27.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vicarious Surgical?
We do not have data on Vicarious Surgical's directors